preloader

Pubblicazioni scientifiche di maggior interesse

  • Home
  • Pubblicazioni scientifiche di maggior interesse

Pubblicazioni scientifiche di maggior interesse

1.

Botulinum Toxin Off-Label Use in Dermatology: A Review.

Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A.Campanati A, et al.Skin Appendage Disord. 2017 Mar;3(1):39-56. doi: 10.1159/000452341. Epub 2017 Feb 1.Skin Appendage Disord. 2017.PMID: 28612001Free PMC article.Review.
2.

Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.

Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R.Marzano AV, et al.J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7.J Eur Acad Dermatol Venereol. 2019.PMID: 30451325Clinical Trial.
3.

Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face.

Puviani M, Campione E, Offidani AM, De Grandi R, Bianchi L, Bobyr I, Giannoni M, Campanati A, Bottagisio M, Bidossi A, De Vecchi E, Eisendle K, Milani M.Puviani M, et al.Clin Cosmet Investig Dermatol. 2019 May 2;12:285-293. doi: 10.2147/CCID.S205904. eCollection 2019.Clin Cosmet Investig Dermatol. 2019.PMID: 31190937Free PMC article.
4.

Efficacy and safety of switching to ixekizumab in secukinumab nonresponder patients with psoriasis: results from a multicentre experience.

Conti A, Peccerillo F, Amerio P, Balato A, Bardazzi F, Bianchi L, Burlando M, Cannavò SP, Chiricozzi A, Dapavo P, De Simone C, Fargnoli MC, Gambardella A, Gisondi P, Malagoli P, Malara G, Mugheddu C, Offidani AM, Piaserico S, Prignano F, Stingeni L, Pellacani G.Conti A, et al.Br J Dermatol. 2019 Jun;180(6):1547-1548. doi: 10.1111/bjd.17580. Epub 2019 Feb 21.Br J Dermatol. 2019.PMID: 30578668No abstract available.
5.

Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis.

Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, Costanzo A, Conti A, Dapavo P, De Simone C, Foti C, Naldi L, Offidani A, Parodi A, Piaserico S, Prignano F, Rongioletti F, Stingeni L, Talamonti M, Girolomoni G.Gisondi P, et al.J Eur Acad Dermatol Venereol. 2017 May;31(5):774-790. doi: 10.1111/jdv.14114. Epub 2017 Feb 27.J Eur Acad Dermatol Venereol. 2017.PMID: 28244153
6.

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

Rizzello F, Olivieri I, Armuzzi A, Ayala F, Bettoli V, Bianchi L, Cimino L, Costanzo A, Cristaudo A, D’Angelo S, Daperno M, Fostini AC, Galeazzi M, Gilio M, Gionchetti P, Gisondi P, Lubrano E, Marchesoni A, Offidani A, Orlando A, Pugliese D, Salvarani C, Scarpa R, Vecchi M, Girolomoni G.Rizzello F, et al.Adv Ther. 2018 Apr;35(4):545-562. doi: 10.1007/s12325-018-0672-6. Epub 2018 Mar 7.Adv Ther. 2018.PMID: 29516409Free PMC article.
7.

Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines.

Offidani A, Molinelli E, Sechi A, Brisigotti V, Campanati A, Raone B, Neri I, Patrizi A.Offidani A, et al.J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:28-31. doi: 10.1111/jdv.15827.J Eur Acad Dermatol Venereol. 2019.PMID: 31535767
8.

Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic.

Luchetti MM, Benfaremo D, Campanati A, Molinelli E, Ciferri M, Cataldi S, Capeci W, Di Carlo M, Offidani AM, Salaffi F, Gabrielli A.Luchetti MM, et al.Clin Rheumatol. 2018 Oct;37(10):2741-2749. doi: 10.1007/s10067-018-4238-4. Epub 2018 Jul 29.Clin Rheumatol. 2018.PMID: 30056525
9.

Efficacy of Pexiganan Combination with Tigecycline in a Mouse Model of Pseudomonas aeruginosa Sepsis.

Cirioni O, Simonetti O, Morroni G, Brescini L, Kamysz W, Kamysz E, Orlando F, Pierpaoli E, Caffarini M, Orciani M, Agostinelli C, Offidani A, Provinciali M, Giacometti A.Cirioni O, et al.Curr Top Med Chem. 2018;18(24):2127-2132. doi: 10.2174/1568026619666181219123431.Curr Top Med Chem. 2018.PMID: 30569865
10.

Italian Guidelines in diagnosis and treatment of alopecia areata.

Rossi A, Muscianese M, Piraccini BM, Starace M, Carlesimo M, Mandel VD, Alessandrini A, Calvieri S, Caro G, D’arino A, Federico A, Magri F, Pigliacelli F, Amendolagine G, Annunziata MC, Arisi MC, Astorino S, Babino G, Bardazzi F, Barruscotti S, Belloni Fortina A, Borghi A, Bruni F, Caccavale S, Calzavara-Pinton P, Cameli N, Cardone M, Carugno A, Coppola R, Dattola A, De Felici Del Giudice MB, Di Cesare A, Dika E, Di Nunno D, D’ovidio R, Fabbrocini G, Feliciani C, Fulgione E, Galluzzo M, Garcovich S, Garelli V, Guerriero C, Hansel K, La Placa M, Lacarrubba F, Lora V, Marinello E, Megna M, Micali G, Misciali C, Monari P, Monfrecola G, Neri I, Offidani A, Orlando G, Papini M, Patrizi A, Piaserico S, Rivetti N, Simonetti O, Stan TR, Stingeni L, Talamonti M, Tassone F, Villa L, Vincenzi C, Fortuna MC.Rossi A, et al.G Ital Dermatol Venereol. 2019 Dec;154(6):609-623. doi: 10.23736/S0392-0488.19.06458-7. Epub 2019 Sep 26.G Ital Dermatol Venereol. 2019.PMID: 31578836
11.

Improving the disease awareness: how a communication campaign brings hidradenitis suppurativa to the light.

Ribero S, Dapavo P, Casalegno C; HS Awareness Working Group.Ribero S, et al.J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:7-9. doi: 10.1111/jdv.15828.J Eur Acad Dermatol Venereol. 2019.PMID: 31535765
12.

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis.

Fargnoli MC, Esposito M, Ferrucci S, Girolomoni G, Offidani A, Patrizi A, Peris K, Costanzo A, Malara G, Pellacani G, Romanelli M, Amerio P, Cristaudo A, Flori ML, Motolese A, Betto P, Patruno C, Pigatto P, Sirna R, Stinco G, Zalaudek I, Bianchi L, Boccaletti V, Cannavò SP, Cusano F, Lembo S, Mozzillo R, Gallo R, Potenza C, Rongioletti F, Tiberio R, Grieco T, Micali G, Persechino S, Pettinato M, Pucci S, Savi E, Stingeni L, Romano A, Argenziano G; Dupilumab Italian National Access Program (Dup-INAP group).Fargnoli MC, et al.J Dermatolog Treat. 2019 Oct 28:1-7. doi: 10.1080/09546634.2019.1682503. Online ahead of print.J Dermatolog Treat. 2019.PMID: 31647347
13.

A validation study of the Simple Psoriatic Arthritis Screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis.

Salaffi F, Di Carlo M, Luchetti MM, Di Donato E, Campanati A, Benfaremo D, Nicolini M, Carotti M, Giacchetti A, Ganzetti G, Bugatti L, Gabrielli A, Offidani AM.Salaffi F, et al.Clin Exp Rheumatol. 2018 Jan-Feb;36(1):127-135. Epub 2017 Nov 16.Clin Exp Rheumatol. 2018.PMID: 29148421Clinical Trial.
14.

Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group.

Ganzetti G, Campanati A, Bettacchi A, Brandozzi G, Brisigotti V, Bugatti L, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.Ganzetti G, et al.G Ital Dermatol Venereol. 2018 Feb;153(1):5-10. doi: 10.23736/S0392-0488.16.05463-8. Epub 2016 Nov 15.G Ital Dermatol Venereol. 2018.PMID: 27845513
15.

Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage.

Campanati A, Martina E, Giuliodori K, Bobyr I, Consales V, Offidani A.Campanati A, et al.Dermatol Ther. 2019 May;32(3):e12841. doi: 10.1111/dth.12841. Epub 2019 Feb 10.Dermatol Ther. 2019.PMID: 30693648
16.

Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone.

Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A.Molinelli E, et al.Expert Opin Drug Metab Toxicol. 2019 May;15(5):367-379. doi: 10.1080/17425255.2019.1600670. Epub 2019 Apr 19.Expert Opin Drug Metab Toxicol. 2019.PMID: 30943794Review.
17.

Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.

Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara-Pinton P; Cutaneous Immunology group of SIDeMaST.Cozzani E, et al.G Ital Dermatol Venereol. 2018 Jun;153(3):305-315. doi: 10.23736/S0392-0488.18.06006-6. Epub 2018 Mar 30.G Ital Dermatol Venereol. 2018.PMID: 29600832
18.

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: results from extension phase of the SUPREME study.

Papini M, Cusano F, Romanelli M, Burlando M, Stinco G, Girolomoni G, Peris K, Potenza C, Offidani A, Bartezaghi M, Aloisi E, Costanzo A; SUPREME study group.Papini M, et al.Br J Dermatol. 2019 Aug;181(2):413-414. doi: 10.1111/bjd.18013. Epub 2019 May 29.Br J Dermatol. 2019.PMID: 31001812No abstract available.
19.

The place of botulinum toxin type A in the treatment of focal hyperhidrosis.

Lowe N, Campanati A, Bodokh I, Cliff S, Jaen P, Kreyden O, Naumann M, Offidani A, Vadoud J, Hamm H.Lowe N, et al.Br J Dermatol. 2004 Dec;151(6):1115-22. doi: 10.1111/j.1365-2133.2004.06317.x.Br J Dermatol. 2004.PMID: 15606505Review.
20.

Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literature.

Diotallevi F, Campanati A, Radi G, Brisigotti V, Molinelli E, Brancorsini D, Offidani A.Diotallevi F, et al.Dermatol Ther. 2019 Jul;32(4):e12928. doi: 10.1111/dth.12928. Epub 2019 Jun 3.Dermatol Ther. 2019.PMID: 30980454Review.
21.

Omalizumab in Chronic Urticaria: An Italian Survey.

Damiani G, Diani M, Conic RRZ, Colli L, Ferrucci S, Martina E, Offidani AM, Pigatto PDM.Damiani G, et al.Int Arch Allergy Immunol. 2019;178(1):45-49. doi: 10.1159/000492532. Epub 2018 Nov 5.Int Arch Allergy Immunol. 2019.PMID: 30396176Clinical Trial.
22.

Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis.

Campanati A, Paolinelli M, Diotallevi F, Martina E, Molinelli E, Offidani A.Campanati A, et al.Expert Opin Drug Metab Toxicol. 2019 Nov;15(11):913-925. doi: 10.1080/17425255.2019.1681969. Epub 2019 Oct 29.Expert Opin Drug Metab Toxicol. 2019.PMID: 31623470Review.
23.

Nicotinamide N-methyltransferase in nonmelanoma skin cancers.

Pompei V, Salvolini E, Rubini C, Lucarini G, Molinelli E, Brisigotti V, Pozzi V, Sartini D, Campanati A, Offidani A, Emanuelli M.Pompei V, et al.Eur J Clin Invest. 2019 Dec;49(12):e13175. doi: 10.1111/eci.13175. Epub 2019 Oct 26.Eur J Clin Invest. 2019.PMID: 31571214
24.

A multicenter retrospective case-control study on Suspension of TNF-inhibitors and Outcomes in Psoriatic patients (STOP study).

Stinco G, Balato N, Buligan C, Campanati A, Dastoli S, Di Meo N, Gisondi P, Lacarubba F, Musumeci ML, Napolitano M, Offidani A, Pescitelli L, Piaserico S, Piccirillo A, Prignano F, Errichetti E.Stinco G, et al.G Ital Dermatol Venereol. 2019 Aug;154(4):392-399. doi: 10.23736/S0392-0488.18.06156-4. Epub 2018 Sep 24.G Ital Dermatol Venereol. 2019.PMID: 30251810Clinical Trial.
25.

HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa.

Peris K, Lo Schiavo A, Fabbrocini G, Dini V, Patrizi A, Fusano M, Bianchi L, Guanziroli E, Guarneri C, Parodi A, Bertoldi A, Musumeci ML, Offidani A, Rongioletti F, Pistone G, Malara G, Potenza C, Casari A, Franchi C, Ardigò M, Cusano F, Stingeni L, Amerio P, Mancini LL, Prignano F, Deboli T, Gualberti G, Saragaglia V, Bettoli V.Peris K, et al.J Eur Acad Dermatol Venereol. 2019 Apr;33(4):766-773. doi: 10.1111/jdv.15425. Epub 2019 Mar 5.J Eur Acad Dermatol Venereol. 2019.PMID: 30633405Free PMC article.Clinical Trial.
26.

Italian Guidelines in Pemphigus – adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV).

Feliciani C, Cozzani E, Marzano AV, Caproni M, Di Zenzo G, Calzavara-Pinton P; “Cutaneous Immunology” group of SIDeMaST.Feliciani C, et al.G Ital Dermatol Venereol. 2018 Oct;153(5):599-608. doi: 10.23736/S0392-0488.18.06073-X. Epub 2018 May 31.G Ital Dermatol Venereol. 2018.PMID: 29860771
27.

Merkel cell carcinoma: a systematic review of ENT presentations.

Gioacchini FM, Postacchini V, Simonetti O, Offidani A, Magliulo G, Re M.Gioacchini FM, et al.Eur Arch Otorhinolaryngol. 2013 Aug;270(8):2191-9. doi: 10.1007/s00405-012-2283-1. Epub 2012 Nov 29.Eur Arch Otorhinolaryngol. 2013.PMID: 23192664Review.
28.

Photoprotection and photodermatitis: a case.

Martina E, Rosa L, Postacchini V, Simonetti O, Cataldi I, Offidani A.Martina E, et al.Contact Dermatitis. 2017 Jan;76(1):54-55. doi: 10.1111/cod.12644.Contact Dermatitis. 2017.PMID: 27957757No abstract available.
29.

Correlation between lipoprotein(a) and lipid peroxidation in psoriasis: role of the enzyme paraoxonase-1.

Ferretti G, Bacchetti T, Campanati A, Simonetti O, Liberati G, Offidani A.Ferretti G, et al.Br J Dermatol. 2012 Jan;166(1):204-7. doi: 10.1111/j.1365-2133.2011.10539.x.Br J Dermatol. 2012.PMID: 21790517
30.

“SENECA” Sinecatechins 10% ointment: A green tea extract for the treatment of actinic keratosis. Case series.

Bobyr I, Campanati A, Offidani A.Bobyr I, et al.Dermatol Ther. 2018 Sep;31(5):e12634. doi: 10.1111/dth.12634. Epub 2018 Sep 2.Dermatol Ther. 2018.PMID: 30175472No abstract available.
31.

Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Ganzetti G, Campanati A, Molinelli E, Offidani A.Ganzetti G, et al.World J Cardiol. 2016 Feb 26;8(2):120-31. doi: 10.4330/wjc.v8.i2.120.World J Cardiol. 2016.PMID: 26981209Free PMC article.Review.
32.

In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds.

Morroni G, Simonetti O, Brenciani A, Brescini L, Kamysz W, Kamysz E, Neubauer D, Caffarini M, Orciani M, Giovanetti E, Offidani A, Giacometti A, Cirioni O.Morroni G, et al.Med Microbiol Immunol. 2019 Dec;208(6):877-883. doi: 10.1007/s00430-019-00624-7. Epub 2019 Jun 18.Med Microbiol Immunol. 2019.PMID: 31214759
33.

Relapsing acute generalized exanthematous pustolosis: a guess.

Consales V, Campanati A, Bobyr I, Molinelli E, Brisigotti V, Giuliodori K, Ganzetti G, Giangiacomi M, Offidani A.Consales V, et al.G Ital Dermatol Venereol. 2019 Feb;154(1):82-83. doi: 10.23736/S0392-0488.16.05292-5.G Ital Dermatol Venereol. 2019.PMID: 30616333No abstract available.
34.

Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients.

Fabbrocini G, Marasca C, Megna M, Peris K; HS Quality of Life Study Group.Fabbrocini G, et al.J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:25-27. doi: 10.1111/jdv.15821.J Eur Acad Dermatol Venereol. 2019.PMID: 31535761
35.

Sneddon-Wilkinson Disease and Monoclonal Gammopathy of Undetermined Significance in the Elderly: Case Report.

Ceccarelli G, Molinelli E, Campanati A, Goteri G, Offidani A.Ceccarelli G, et al.Case Rep Dermatol. 2019 Jul 10;11(2):209-214. doi: 10.1159/000487003. eCollection 2019 May-Aug.Case Rep Dermatol. 2019.PMID: 31427943Free PMC article.
36.

Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance.

Caffarini M, Armeni T, Pellegrino P, Cianfruglia L, Martino M, Offidani A, Di Benedetto G, Arnaldi G, Campanati A, Orciani M.Caffarini M, et al.Front Cell Dev Biol. 2019 Oct 9;7:227. doi: 10.3389/fcell.2019.00227. eCollection 2019.Front Cell Dev Biol. 2019.PMID: 31649930Free PMC article.
37.

Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.

Prattichizzo F, Giuliani A, Recchioni R, Bonafè M, Marcheselli F, De Carolis S, Campanati A, Giuliodori K, Rippo MR, Brugè F, Tiano L, Micucci C, Ceriello A, Offidani A, Procopio AD, Olivieri F.Prattichizzo F, et al.Oncotarget. 2016 Mar 15;7(11):11945-58. doi: 10.18632/oncotarget.7858.Oncotarget. 2016.PMID: 26943583Free PMC article.
38.

Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.

Campanati A, Giuliodori K, Martina E, Giuliano A, Ganzetti G, Offidani A.Campanati A, et al.J Neural Transm (Vienna). 2014 Jan;121(1):21-6. doi: 10.1007/s00702-013-1074-1. Epub 2013 Sep 20.J Neural Transm (Vienna). 2014.PMID: 24052109Clinical Trial.
39.

Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach.

Campanati A, Giuliodori K, Giuliano A, Martina E, Ganzetti G, Marconi B, Chiarici A, Offidani A.Campanati A, et al.Arch Dermatol Res. 2013 Oct;305(8):691-7. doi: 10.1007/s00403-013-1380-3. Epub 2013 Jun 26.Arch Dermatol Res. 2013.PMID: 23800969
40.

Kaposi-Juliusberg varicelliform eruption in patients suffering from Darier-White Disease: a case report and review of the literature.

Molinelli E, Ricotti F, Campanati A, Cataldi I, Ganzetti G, Liberati G, Bianchelli T, Offidani A.Molinelli E, et al.G Ital Dermatol Venereol. 2016 Oct;151(5):558-61. Epub 2014 Dec 11.G Ital Dermatol Venereol. 2016.PMID: 25502366Review.
41.

Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience.

Diotallevi F, Campanati A, Radi G, Molinelli E, Offidani A.Diotallevi F, et al.G Ital Dermatol Venereol. 2018 Nov 9. doi: 10.23736/S0392-0488.18.06094-7. Online ahead of print.G Ital Dermatol Venereol. 2018.PMID: 30428651
42.

Saliva and Oral Diseases.

Martina E, Campanati A, Diotallevi F, Offidani A.Martina E, et al.J Clin Med. 2020 Feb 8;9(2):466. doi: 10.3390/jcm9020466.J Clin Med. 2020.PMID: 32046271Free PMC article.Review.
43.

Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study.

Costanzo A, Bianchi L, Flori ML, Malara G, Stingeni L, Bartezaghi M, Carraro L, Castellino G; SUPREME Study Group.Costanzo A, et al.Br J Dermatol. 2018 Nov;179(5):1072-1080. doi: 10.1111/bjd.16705. Epub 2018 Aug 14.Br J Dermatol. 2018.PMID: 29704432Clinical Trial.
44.

Psoriasis beyond the skin surface: a pilot study on the ocular involvement.

Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E, Herbort CP, Mariotti C, Giovannini A, Offidani A.Campanati A, et al.Int Ophthalmol. 2015 Jun;35(3):331-40. doi: 10.1007/s10792-014-9950-8. Epub 2014 May 6.Int Ophthalmol. 2015.PMID: 24799345
45.

Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature.

Campanati A, Ganzetti G, Martina E, Giannoni M, Gesuita R, Bendia E, Giuliodori K, Sandroni L, Offidani A.Campanati A, et al.Int J Dermatol. 2015;54(5):e109-14. doi: 10.1111/ijd.12798. Epub 2015 Mar 23.Int J Dermatol. 2015.PMID: 25808243Review.
46.

Ultrasonography in the pathway to an optimal standard of care of hidradenitis suppurativa: the Italian Ultrasound Working Group experience.

Lacarrubba F, Dini V, Napolitano M, Venturini M, Caposiena Caro DR, Molinelli E, Passoni E, Monfrecola G; Italian Ultrasound Working Group.Lacarrubba F, et al.J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:10-14. doi: 10.1111/jdv.15847.J Eur Acad Dermatol Venereol. 2019.PMID: 31535763
47.

Effectiveness of etanercept in children with plaque psoriasis in real practice: a one-year multicenter retrospective study.

Di Lernia V, Guarneri C, Stingeni L, Gisondi P, Bonamonte D, Calzavara Pinton PG, Offidani A, Hansel K, Girolomoni G, Filoni A, Belloni Fortina A, Ficarelli E, Cannavò SP.Di Lernia V, et al.J Dermatolog Treat. 2018 May;29(3):217-219. doi: 10.1080/09546634.2017.1364692. Epub 2017 Aug 18.J Dermatolog Treat. 2018.PMID: 28783991Clinical Trial.
48.

Osteopontin: a new facilitating factor in alopecia areata pathogenesis?

Ganzetti G, Simonetti O, Campanati A, Giuliodori K, Scocco V, Brugia M, Tocchini M, Offidani A.Ganzetti G, et al.Acta Dermatovenerol Croat. 2015;23(1):19-22.Acta Dermatovenerol Croat. 2015.PMID: 25969908
49.

A patient with psoriasis and vitiligo treated with etanercept.

Campanati A, Giuliodori K, Ganzetti G, Liberati G, Offidani AM.Campanati A, et al.Am J Clin Dermatol. 2010;11 Suppl 1:46-8. doi: 10.2165/1153424-S0-000000000-00000.Am J Clin Dermatol. 2010.PMID: 20586509
50.

Secukinumab in multi-failure psoriatic patients: the last hope?

Magnano M, Loi C, Patrizi A, Sgubbi P, Balestri R, Rech G, Tasin L, Girardelli CR, Conti A, Odorici G, Campanati A, Offidani AM, Bardazzi F.Magnano M, et al.J Dermatolog Treat. 2018 Sep;29(6):583-585. doi: 10.1080/09546634.2018.1427206. Epub 2018 Jan 23.J Dermatolog Treat. 2018.PMID: 29334270
51.

Certolizumab pegol for the treatment of psoriasis.

Campanati A, Benfaremo D, Luchetti MM, Ganzetti G, Gabrielli A, Offidani A.Campanati A, et al.Expert Opin Biol Ther. 2017 Mar;17(3):387-394. doi: 10.1080/14712598.2017.1283401. Epub 2017 Feb 6.Expert Opin Biol Ther. 2017.PMID: 28165828Review.
52.

Dermoscopic features of conjunctival melanocytic lesions.

Brisigotti V, De Blasio S, Cellini A, Ganzetti G, Giangiacomi M, Frongia GB, Campanati A, Offidani A.Brisigotti V, et al.G Ital Dermatol Venereol. 2018 Dec;153(6):878-881. doi: 10.23736/S0392-0488.16.05411-0.G Ital Dermatol Venereol. 2018.PMID: 30518179No abstract available.
53.

Optimizing a clinical guidance for diagnosis of atopic dermatitis in adults: joint recommendations of the Italian Society of Dermatology and Venereology (SIDeMaST), Italian Association of Hospital Dermatologists (ADOI), and Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA).

Patruno C, Amerio P, Chiricozzi A, Costanzo A, Cristaudo A, Cusano F, Foti C, Girolomoni G, Guarneri F, Naldi L, Offidani A, Pigatto P, Prignano F, Stingeni L, Calzavara-Pinton P.Patruno C, et al.G Ital Dermatol Venereol. 2020 Feb;155(1):1-7. doi: 10.23736/S0392-0488.19.06522-2. Epub 2019 Dec 16.G Ital Dermatol Venereol. 2020.PMID: 31840484
54.

Atypical neurothekeoma: a new case and review of the literature.

Campanati A, Brandozzi G, Sisti S, Bernardini ML, Offidani AM.Campanati A, et al.J Cutan Pathol. 2007 May;34(5):435-7. doi: 10.1111/j.1600-0560.2006.00637.x.J Cutan Pathol. 2007.PMID: 17448203
55.

Ingenol mebutate in actinic keratosis: a clinical, videodermoscopic and immunohistochemical study.

Bobyr I, Campanati A, Consales V, Martina E, Molinelli E, Diotallevi F, Brisigotti V, Giangiacomi M, Ganzetti G, Giuliodori K, Offidani A.Bobyr I, et al.J Eur Acad Dermatol Venereol. 2017 Feb;31(2):260-266. doi: 10.1111/jdv.13831. Epub 2016 Jul 25.J Eur Acad Dermatol Venereol. 2017.PMID: 27453064Clinical Trial.
56.

Biologic Therapy in Psoriasis: Safety Profile.

Campanati A, Ganzetti G, Giuliodori K, Molinelli E, Offidani A.Campanati A, et al.Curr Drug Saf. 2016;11(1):4-11. doi: 10.2174/1574886310666151014115532.Curr Drug Saf. 2016.PMID: 26463245Review.
57.

Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore.

Marzano AV, Chiricozzi A, Giovanardi G, Argenziano G, Bettoli V, Bianchi L, Dapavo P, Dini V, Fabbrocini G, Micali G, Offidani AM, Potenza C, Prignano F, Gualberti G, Saragaglia V, Rongioletti F.Marzano AV, et al.J Eur Acad Dermatol Venereol. 2020 Mar 2. doi: 10.1111/jdv.16328. Online ahead of print.J Eur Acad Dermatol Venereol. 2020.PMID: 32119143
58.

Effectiveness of antimicrobial photodynamic therapy with a single treatment of RLP068/Cl in an experimental model of Staphylococcus aureus wound infection.

Simonetti O, Cirioni O, Orlando F, Alongi C, Lucarini G, Silvestri C, Zizzi A, Fantetti L, Roncucci G, Giacometti A, Offidani A, Provinciali M.Simonetti O, et al.Br J Dermatol. 2011 May;164(5):987-95. doi: 10.1111/j.1365-2133.2011.10232.x. Epub 2011 Apr 5.Br J Dermatol. 2011.PMID: 21275941
59.

Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological clinic of a ii level hospital.

Radi G, Diotallevi F, Campanati A, Offidani A.Radi G, et al.J Eur Acad Dermatol Venereol. 2020 Mar 22. doi: 10.1111/jdv.16386. Online ahead of print.J Eur Acad Dermatol Venereol. 2020.PMID: 32201972
60.

Cutaneous vasculitis and inflammatory bowel diseases.

Simonetti O, Postacchini V, Offidani A.Simonetti O, et al.G Ital Dermatol Venereol. 2015 Apr;150(2):233-6. Epub 2015 Mar 31.G Ital Dermatol Venereol. 2015.PMID: 25830412Review.
61.

Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.

Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.Campanati A, et al.J Eur Acad Dermatol Venereol. 2011 Aug;25(8):917-21. doi: 10.1111/j.1468-3083.2010.03880.x. Epub 2010 Nov 4.J Eur Acad Dermatol Venereol. 2011.PMID: 21054569
62.

Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis.

Bobyr I, Campanati A, Giacchetti A, Offidani A.Bobyr I, et al.Photodermatol Photoimmunol Photomed. 2019 Jul;35(4):277-279. doi: 10.1111/phpp.12452. Epub 2019 Feb 18.Photodermatol Photoimmunol Photomed. 2019.PMID: 30690758Clinical Trial.No abstract available.
63.

Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model.

Simonetti O, Cirioni O, Goteri G, Ghiselli R, Kamysz W, Kamysz E, Silvestri C, Orlando F, Barucca C, Scalise A, Saba V, Scalise G, Giacometti A, Offidani A.Simonetti O, et al.Peptides. 2008 Apr;29(4):520-8. doi: 10.1016/j.peptides.2007.12.011. Epub 2008 Jan 3.Peptides. 2008.PMID: 18255189
64.

Hidradenitis suppurativa epidemiology: from the first Italian registry in 2009 to the most recent epidemiology updates – Italian Registry Hidradenitis Suppurativa project 2.

Bettoli V, Cazzaniga S, Scuderi V, Zedde P, Di Landro A, Naldi L; IRHIS Group.Bettoli V, et al.J Eur Acad Dermatol Venereol. 2019 Oct;33 Suppl 6:4-6. doi: 10.1111/jdv.15826.J Eur Acad Dermatol Venereol. 2019.PMID: 31535758
65.

Hidradenoma papilliferum: diagnostic challenge.

Campanati A, Giuliodori K, Ganzetti G, Liberati G, Cellini A, Giangiacomi M, Marconi B, Lemme G, Offidani A.Campanati A, et al.G Ital Dermatol Venereol. 2016 Feb;151(1):112-4. Epub 2014 Nov 12.G Ital Dermatol Venereol. 2016.PMID: 25387849No abstract available.
66.

Hidradenitis suppurativa in Crohn’s disease during adalimumab therapy: a paradox?

Martina E, Campanati A, Giuliodori K, Offidani A.Martina E, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2017 Mar;26(1):21-23. doi: 10.15570/actaapa.2017.6.Acta Dermatovenerol Alp Pannonica Adriat. 2017.PMID: 28352932
67.

Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis.

Cirioni O, Simonetti O, Pierpaoli E, Barucca A, Ghiselli R, Orlando F, Pelloni M, Trombettoni MM, Guerrieri M, Offidani A, Giacometti A, Provinciali M.Cirioni O, et al.Diagn Microbiol Infect Dis. 2016 Dec;86(4):392-398. doi: 10.1016/j.diagmicrobio.2016.09.010. Epub 2016 Sep 17.Diagn Microbiol Infect Dis. 2016.PMID: 27712928
68.

Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Ganzetti G, Campanati A, Offidani A.Ganzetti G, et al.World J Hepatol. 2015 Mar 27;7(3):315-26. doi: 10.4254/wjh.v7.i3.315.World J Hepatol. 2015.PMID: 25848461Free PMC article.Review.
69.

Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment.

Marconi B, Bobyr I, Campanati A, Molinelli E, Consales V, Brisigotti V, Scarpelli M, Racchini S, Offidani A.Marconi B, et al.Intractable Rare Dis Res. 2015 Aug;4(3):113-22. doi: 10.5582/irdr.2015.01014.Intractable Rare Dis Res. 2015.PMID: 26361562Free PMC article.Review.
70.

Involvement of the oral cavity in psoriasis: results of a clinical study.

Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A.Ganzetti G, et al.Br J Dermatol. 2015 Jan;172(1):282-5. doi: 10.1111/bjd.13201. Epub 2014 Nov 30.Br J Dermatol. 2015.PMID: 25078556No abstract available.
71.

Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives.

Campanati A, Consales V, Orciani M, Giuliodori K, Ganzetti G, Bobyr I, Sorgentoni G, di Primio R, Offidani A.Campanati A, et al.Psoriasis (Auckl). 2017 Nov 27;7:73-85. doi: 10.2147/PTT.S108311. eCollection 2017.Psoriasis (Auckl). 2017.PMID: 29387610Free PMC article.Review.
72.

IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study.

Ganzetti G, Rubini C, Campanati A, Zizzi A, Molinelli E, Rosa L, Simonacci F, Offidani A.Ganzetti G, et al.Melanoma Res. 2015 Jun;25(3):232-8. doi: 10.1097/CMR.0000000000000151.Melanoma Res. 2015.PMID: 25793426
73.

Mycosis Fungoides-like Eruption and Infliximab.

Ganzetti G, Molinelli E, Campanati A, Brisigotti V, Goteri G, Consales V, Racchini S, Bendia E, di Sario A, Benedetti A, Offidani A.Ganzetti G, et al.J Clin Gastroenterol. 2016 Aug;50(7):610-1. doi: 10.1097/MCG.0000000000000517.J Clin Gastroenterol. 2016.PMID: 26974764No abstract available.
74.

Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile.

Ganzetti G, Campanati A, Molinelli E, Offidani A.Ganzetti G, et al.Curr Drug Saf. 2016;11(1):12-21. doi: 10.2174/1574886310666151014121732.Curr Drug Saf. 2016.PMID: 26463243Review.
75.

VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study.

Simonetti O, Lucarini G, Goteri G, Zizzi A, Biagini G, Lo Muzio L, Offidani A.Simonetti O, et al.Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):751-60. doi: 10.1177/039463200601900405.Int J Immunopathol Pharmacol. 2006.PMID: 17166397
76.

Oxybutynin for the Treatment of Primary Hyperhidrosis: Current State of the Art.

Campanati A, Gregoriou S, Kontochristopoulos G, Offidani A.Campanati A, et al.Skin Appendage Disord. 2015 Mar;1(1):6-13. doi: 10.1159/000371581. Epub 2015 Jan 30.Skin Appendage Disord. 2015.PMID: 27172124Free PMC article.Review.
77.

Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways.

Molinelli E, Campanati A, Brisigotti V, Offidani A.Molinelli E, et al.Curr Pharm Biotechnol. 2017;18(12):964-978. doi: 10.2174/1389201019666180103140643.Curr Pharm Biotechnol. 2017.PMID: 29299984Review.
78.

Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.

Ganzetti G, Sartini D, Campanati A, Rubini C, Molinelli E, Brisigotti V, Cecati M, Pozzi V, Campagna R, Offidani A, Emanuelli M.Ganzetti G, et al.Melanoma Res. 2018 Apr;28(2):82-88. doi: 10.1097/CMR.0000000000000430.Melanoma Res. 2018.PMID: 29420365
79.

Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series.

Bobyr I, Campanati A, Consales V, Giuliodori K, Scalise A, Offidani A.Bobyr I, et al.Springerplus. 2016 May 14;5:627. doi: 10.1186/s40064-016-2290-6. eCollection 2016.Springerplus. 2016.PMID: 27330893Free PMC article.
80.

MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab.

Mensà E, Recchioni R, Marcheselli F, Giuliodori K, Consales V, Molinelli E, Prattichizzo F, Rippo MR, Campanati A, Procopio AD, Olivieri F, Offidani AM.Mensà E, et al.Br J Dermatol. 2018 Sep;179(3):787-789. doi: 10.1111/bjd.16659. Epub 2018 Aug 20.Br J Dermatol. 2018.PMID: 29624637Clinical Trial.No abstract available.
81.

Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases.

Ricotti F, Giuliodori K, Cataldi I, Campanati A, Ganzetti G, Ricotti G, Offidani A.Ricotti F, et al.Dermatol Ther. 2014 May-Jun;27(3):148-52. doi: 10.1111/dth.12098. Epub 2013 Sep 24.Dermatol Ther. 2014.PMID: 24903471Clinical Trial.
82.

Familial lupus panniculitis: two cases, same diagnosis, what evolution?

Molinelli E, Campanati A, Brisigotti V, Diotallevi F, Radi G, Racchini S, Giangiacomi M, Offidani A.Molinelli E, et al.G Ital Dermatol Venereol. 2019 Jan 9. doi: 10.23736/S0392-0488.18.06151-5. Online ahead of print.G Ital Dermatol Venereol. 2019.PMID: 30636398No abstract available.
83.

Active inflammatory biomarkers in oral lichen planus.

Santarelli A, Mascitti M, Rubini C, Bambini F, Zizzi A, Offidani A, Ganzetti G, Laino L, Cicciù M, Lo Muzio L.Santarelli A, et al.Int J Immunopathol Pharmacol. 2015 Dec;28(4):562-8. doi: 10.1177/0394632015592101. Epub 2015 Aug 24.Int J Immunopathol Pharmacol. 2015.PMID: 26303119
84.

Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.

Campanati A, Bernardini ML, Gesuita R, Offidani A.Campanati A, et al.Eur J Dermatol. 2007 Jan-Feb;17(1):52-4. doi: 10.1684/ejd.2007.0094. Epub 2007 Feb 27.Eur J Dermatol. 2007.PMID: 17324828
85.

Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- α Inhibitors.

Campanati A, Molinelli E, Brisigotti V, Offidani A.Campanati A, et al.Curr Pharm Biotechnol. 2017;18(12):945-963. doi: 10.2174/1389201019666180209121804.Curr Pharm Biotechnol. 2017.PMID: 29424306Review.
86.

Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts.

Molinelli E, Campanati A, Ganzetti G, Offidani A.Molinelli E, et al.Curr Drug Saf. 2016;11(1):35-43. doi: 10.2174/1574886310666151014115127.Curr Drug Saf. 2016.PMID: 26463248Review.
87.

Alopecia Areata: a possible extraintestinal manifestation of Crohn’s disease.

Ganzetti G, Campanati A, Offidani A.Ganzetti G, et al.J Crohns Colitis. 2012 Oct;6(9):962-3. doi: 10.1016/j.crohns.2012.05.023. Epub 2012 Jun 21.J Crohns Colitis. 2012.PMID: 22727660No abstract available.
88.

Response to letter to the editor: ‘a precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matrices’.

Campanati A, De Blasio S, Giuliano A, Ganzetti G, Giuliodori K, Pecora T, Consales V, Minnetti I, Offidani A.Campanati A, et al.Burns. 2014 May;40(3):534-5. doi: 10.1016/j.burns.2013.12.013. Epub 2014 Feb 1.Burns. 2014.PMID: 24495543No abstract available.
89.

Pathogenetic Characteristics of Mesenchymal Stem Cells in Hidradenitis Suppurativa.

Campanati A, Orciani M, Sorgentoni G, Consales V, Offidani A, Di Primio R.Campanati A, et al.JAMA Dermatol. 2018 Oct 1;154(10):1184-1190. doi: 10.1001/jamadermatol.2018.2516.JAMA Dermatol. 2018.PMID: 30140888Free PMC article.
90.

Doxycycline-isoniazid: a new therapeutic association for recalcitrant acne agminata.

Ganzetti G, Giuliodori K, Campanati A, Simonetti O, Goteri G, Offidani AM.Ganzetti G, et al.Dermatol Ther. 2012 Mar-Apr;25(2):207-9. doi: 10.1111/j.1529-8019.2012.01442.x.Dermatol Ther. 2012.PMID: 22741939
91.

In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections.

Simonetti O, Morroni G, Ghiselli R, Orlando F, Brenciani A, Xhuvelaj L, Provinciali M, Offidani A, Guerrieri M, Giacometti A, Cirioni O.Simonetti O, et al.J Med Microbiol. 2018 Jan;67(1):139-143. doi: 10.1099/jmm.0.000649. Epub 2017 Nov 20.J Med Microbiol. 2018.PMID: 29154746
92.

Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel.

Campanati A, Martina E, Giuliodori K, Ganzetti G, Marconi B, Conta I, Giangiacomi M, Offidani A.Campanati A, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):39-41. doi: 10.15570/actaapa.2014.10.Acta Dermatovenerol Alp Pannonica Adriat. 2014.PMID: 24964949
93.

Efficacy and Safety of Topical Pidobenzone 4% as Adjuvant Treatment for Solar Lentigines: Result of a Randomized, Controlled, Clinical Trial.

Campanati A, Giannoni M, Scalise A, De Blasio S, Giuliano A, Giuliodori K, Ganzetti G, Bolletta E, Di Benedetto G, Offidani A.Campanati A, et al.Dermatology. 2016;232(4):478-83. doi: 10.1159/000447356. Epub 2016 Aug 12.Dermatology. 2016.PMID: 27513344Clinical Trial.
94.

Oxidative stress and psoriasis: the effect of antitumour necrosis factor-α inhibitor treatment.

Bacchetti T, Campanati A, Ferretti G, Simonetti O, Liberati G, Offidani AM.Bacchetti T, et al.Br J Dermatol. 2013 May;168(5):984-9. doi: 10.1111/bjd.12144.Br J Dermatol. 2013.PMID: 23614561Clinical Trial.
95.

A case of pretibial myxoedema associated to ectopic secreting thyroid nodule on thyroglossal duct residue.

Marconi B, Brandozzi G, Galeazzi A, Campanati A, Simonetti O, Santinelli A, Pisa E, Offidani A.Marconi B, et al.J Eur Acad Dermatol Venereol. 2008 May;22(5):620-1. doi: 10.1111/j.1468-3083.2007.02419.x.J Eur Acad Dermatol Venereol. 2008.PMID: 18410622No abstract available.
96.

Homocysteine plasma levels in psoriasis patients: our experience and review of the literature.

Giannoni M, Consales V, Campanati A, Ganzetti G, Giuliodori K, Postacchini V, Liberati G, Azzaretto L, Vichi S, Guanciarossa F, Offidani A.Giannoni M, et al.J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1781-5. doi: 10.1111/jdv.13023. Epub 2015 Mar 23.J Eur Acad Dermatol Venereol. 2015.PMID: 25809089
97.

Indications for excision of nevi and melanoma diagnosed in a pediatric surgical unit.

Zangari A, Bernardini ML, Tallarico R, Ilari M, Giangiacomi M, Offidani AM, Martino A.Zangari A, et al.J Pediatr Surg. 2007 Aug;42(8):1412-6. doi: 10.1016/j.jpedsurg.2007.03.044.J Pediatr Surg. 2007.PMID: 17706506
98.

Evidence for a ‘window of opportunity’ in hidradenitis suppurativa treated with adalimumab: a retrospective, real-life multicentre cohort study.

Marzano AV, Genovese G, Casazza G, Moltrasio C, Dapavo P, Micali G, Sirna R, Gisondi P, Patrizi A, Dini V, Bianchini D, Bianchi L, Fania L, Prignano F, Offidani A, Atzori L, Bettoli V, Cannavò SP, Venturini M, Bongiorno MR, Costanzo A, Fabbrocini G, Peris K.Marzano AV, et al.Br J Dermatol. 2020 Mar 2. doi: 10.1111/bjd.18983. Online ahead of print.Br J Dermatol. 2020.PMID: 32119111
99.

Indirect co-cultures of healthy mesenchymal stem cells restore the physiological phenotypical profile of psoriatic mesenchymal stem cells.

Campanati A, Orciani M, Sorgentoni G, Consales V, Mattioli Belmonte M, Di Primio R, Offidani A.Campanati A, et al.Clin Exp Immunol. 2018 Aug;193(2):234-240. doi: 10.1111/cei.13141. Epub 2018 May 31.Clin Exp Immunol. 2018.PMID: 29676778Free PMC article.
100.

Outcome following a short period of adalimumab dose escalation as rescue therapy in psoriatic patients.

Bardazzi F, Bigi L, Campanati A, Conti A, Di Lernia V, Di Nuzzo S, Kaleci S, Lasagni C, Offidani AM, Giacchetti A, Nicolini M, Bettacchi A, Rosa L, Sacchelli L.Bardazzi F, et al.Eur J Dermatol. 2020 Apr 7. doi: 10.1684/ejd.2020.3751. Online ahead of print.Eur J Dermatol. 2020.PMID: 32266875
101.

Lifelong widespread warts associated with human papillomavirus type 70/85: a new diagnostic entity?

Giuliodori K, Campanati A, Liberati G, Ganzetti G, Giangiacomi M, Marinelli K, Cataldi I, Marconi B, Offidani A.Giuliodori K, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2016;25(1):11-3. doi: 10.15570/actaapa.2016.3.Acta Dermatovenerol Alp Pannonica Adriat. 2016.PMID: 27014773
102.

Analysis of neoplastic skin complications in transplant patients: experience of an italian multidisciplinary transplant unit.

Marconi B, Campanati A, Giannoni M, Ricotti F, Bianchelli T, Offidani A.Marconi B, et al.G Ital Dermatol Venereol. 2018 Sep 18. doi: 10.23736/S0392-0488.18.05974-6. Online ahead of print.G Ital Dermatol Venereol. 2018.PMID: 30229636
103.

Granuloma faciale successfully treated with ingenol mebutate.

Bobyr I, Campanati A, Consales V, Giangiacomi M, Diotallevi F, Offidani A.Bobyr I, et al.Dermatol Ther. 2016 Sep;29(5):325-329. doi: 10.1111/dth.12368. Epub 2016 Jun 30.Dermatol Ther. 2016.PMID: 27364361
104.

Correlation between immunohistochemical staining of CEACAM1 and clinicopathological findings in oral pre-neoplastic lesions and squamous cell carcinoma.

Simonetti O, Lucarini G, Rubini C, Zizzi A, Aspriello SD, Di Primio R, Offidani AM.Simonetti O, et al.Med Mol Morphol. 2018 Mar;51(1):41-47. doi: 10.1007/s00795-017-0169-4. Epub 2017 Sep 8.Med Mol Morphol. 2018.PMID: 28887602
105.

D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness.

Minardi D, d’Anzeo G, Lucarini G, Filosa A, Zizzi A, Simonetti O, Polito M Jr, Offidani AM, Di Primio R, Montironi R, Muzzonigro G.Minardi D, et al.Hum Pathol. 2011 Nov;42(11):1596-602. doi: 10.1016/j.humpath.2010.12.020. Epub 2011 Apr 15.Hum Pathol. 2011.PMID: 21497368
106.

Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.

Bernardini ML, Cangiotti AM, Zamponi N, Porfiri L, Cinti S, Offidani A.Bernardini ML, et al.J Cutan Pathol. 2007 Mar;34(3):270-5. doi: 10.1111/j.1600-0560.2006.00603.x.J Cutan Pathol. 2007.PMID: 17302612
107.

Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance.

Mascitti M, Santarelli A, Sartini D, Rubini C, Colella G, Salvolini E, Ganzetti G, Offidani A, Emanuelli M.Mascitti M, et al.Melanoma Res. 2019 Apr;29(2):151-156. doi: 10.1097/CMR.0000000000000548.Melanoma Res. 2019.PMID: 30431528
108.

Phototherapy as a useful therapeutic option in the treatment of diphenylcyclopropenone-induced vitiligo.

Ganzetti G, Simonetti O, Campanati A, Giuliodori K, Offidani A.Ganzetti G, et al.Acta Derm Venereol. 2010 Nov;90(6):642-3. doi: 10.2340/00015555-0885.Acta Derm Venereol. 2010.PMID: 21057754No abstract available.
109.

Buschke-Ollendorff syndrome in a 6-year-old patient: clinical and histopathological aspects of a rare disease.

Diotallevi F, Simonetti O, Radi G, Martina E, Paolinelli M, Sapigni C, Guanciarossa F, Bianchelli T, Brancorsini D, Offidani A.Diotallevi F, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2020 Mar;29(1):31-33.Acta Dermatovenerol Alp Pannonica Adriat. 2020.PMID: 32206820
110.

The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region.

Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A.Ganzetti G, et al.G Ital Dermatol Venereol. 2016 Aug;151(4):340-6. Epub 2015 Jun 19.G Ital Dermatol Venereol. 2016.PMID: 26091276
111.

Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi’s Varicelliform Eruption.

Campanati A, Molinelli E, Brisigotti V, Brancorsini D, Bobyr I, Diotallevi F, Radi G, Offidani A.Campanati A, et al.Case Rep Dermatol. 2019 Sep 23;11(Suppl 1):4-10. doi: 10.1159/000501992. eCollection 2019 Sep-Dec.Case Rep Dermatol. 2019.PMID: 31662732Free PMC article.
112.

Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Minardi D, Lucarini G, Filosa A, Zizzi A, Simonetti O, Offidani AM, d’Anzeo G, Di Primio R, Montironi R, Muzzonigro G.Minardi D, et al.Cell Oncol (Dordr). 2012 Oct;35(5):377-84. doi: 10.1007/s13402-012-0098-0. Epub 2012 Sep 13.Cell Oncol (Dordr). 2012.PMID: 22972620
113.

Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group.

Napolitano M, Calzavara-Pinton PG, Zanca A, Bianchi L, Caposiena Caro RD, Offidani AM, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Egan CG, Fabbrocini G, Monfrecola G, Lacarrubba F, Musumeci ML, Passoni E, Venturini M, Micali G.Napolitano M, et al.J Eur Acad Dermatol Venereol. 2019 Feb;33(2):e84-e87. doi: 10.1111/jdv.15235. Epub 2018 Sep 25.J Eur Acad Dermatol Venereol. 2019.PMID: 30176092No abstract available.
114.

Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.

Campanati A, Penna L, Guzzo T, Menotta L, Silvestri B, Lagalla G, Gesuita R, Offidani A.Campanati A, et al.Clin Ther. 2003 Jan;25(1):298-308. doi: 10.1016/s0149-2918(03)90041-5.Clin Ther. 2003.PMID: 12637128Clinical Trial.
115.

Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort.

Bianchi L, Caposiena Caro RD, Ganzetti G, Molinelli E, Dini V, Oranges T, Romanelli M, Fabbrocini G, Monfrecola G, Napolitano M, Egan CG, Musumeci ML, Lacarrubba F, Micali G, Passoni E, Calzavara-Pinton PG, Venturini M, Zanca A, Offidani AM.Bianchi L, et al.Clin Exp Dermatol. 2019 Jul;44(5):e177-e180. doi: 10.1111/ced.13861. Epub 2018 Dec 28.Clin Exp Dermatol. 2019.PMID: 30593710
116.

Editorial: The Biologic Era: A Comprehensive Approach for Inflammatory and Immune-mediated Diseases.

Campanati A, Offidani A.Campanati A, et al.Curr Pharm Biotechnol. 2017;18(12):944. doi: 10.2174/138920101812180312163000.Curr Pharm Biotechnol. 2017.PMID: 29578391No abstract available.
117.

Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis.

Campanati A, Ganzetti G, Giuliodori K, Marra M, Bonfigli A, Testa R, Offidani A.Campanati A, et al.Int J Dermatol. 2015 Jul;54(7):839-45. doi: 10.1111/ijd.12706. Epub 2015 Apr 15.Int J Dermatol. 2015.PMID: 25877149
118.

Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature.

Campanati A, Brisigotti V, Ganzetti G, Molinelli E, Giuliodori K, Consales V, Racchini S, Bendia E, Offidani A.Campanati A, et al.J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1245-7. doi: 10.1111/jdv.12703. Epub 2014 Sep 8.J Eur Acad Dermatol Venereol. 2015.PMID: 25200926Review.No abstract available.
119.

A non-responsive chronic autoimmune urticaria in a 12-year-old autistic girl treated with cyclosporin.

Giuliodori K, Ganzetti G, Campanati A, Simonetti O, Marconi B, Offidani A.Giuliodori K, et al.J Eur Acad Dermatol Venereol. 2009 May;23(5):619-20. doi: 10.1111/j.1468-3083.2008.02987.x. Epub 2009 Sep 10.J Eur Acad Dermatol Venereol. 2009.PMID: 18785892No abstract available.
120.

Effect of allium cepa-allantoin-pentaglycan gel on skin hypertrophic scars: clinical and video-capillaroscopic results of an open-label, controlled, nonrandomized clinical trial.

Campanati A, Savelli A, Sandroni L, Marconi B, Giuliano A, Giuliodori K, Ganzetti G, Offidani A.Campanati A, et al.Dermatol Surg. 2010 Sep;36(9):1439-44. doi: 10.1111/j.1524-4725.2010.01654.x. Epub 2010 Jul 8.Dermatol Surg. 2010.PMID: 20626444Clinical Trial.
121.

Bullous pemphigoid of lever and celiac disease: a coincidental occurrence or an unusual association?

Marconi B, Campanati A, Marzioni M, Cataldi I, Brandozzi G, Giuliodori K, Santinelli A, Pisa E, Ganzetti G, Offidani A.Marconi B, et al.G Ital Dermatol Venereol. 2012 Dec;147(6):654-6.G Ital Dermatol Venereol. 2012.PMID: 23149713No abstract available.
122.

Use of infliximab in toxic epidermal necrolysis: a still opened challenge.

Ganzetti G, Campanati A, Simonetti O, Giuliodori K, Giangiacomi M, Lemme G, Offidani A.Ganzetti G, et al.G Ital Dermatol Venereol. 2015 Aug;150(4):467-71. Epub 2014 Nov 13.G Ital Dermatol Venereol. 2015.PMID: 25394212
123.

Topical ozonated oil versus hyaluronic gel for the treatment of partial- to full-thickness second-degree burns: A prospective, comparative, single-blind, non-randomised, controlled clinical trial.

Campanati A, De Blasio S, Giuliano A, Ganzetti G, Giuliodori K, Pecora T, Consales V, Minnetti I, Offidani A.Campanati A, et al.Burns. 2013 Sep;39(6):1178-83. doi: 10.1016/j.burns.2013.03.002. Epub 2013 Apr 8.Burns. 2013.PMID: 23579036Clinical Trial.
124.

Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis.

DI Lernia V, Neri I, Calzavara Pinton P, DI Nuzzo S, Stingeni L, Guarneri C, Belloni Fortina A, Bonamonte D, Cambiaghi S, Lasagni C, Panzone M, Corazza M, Offidani A, Gisondi P.DI Lernia V, et al.G Ital Dermatol Venereol. 2017 Aug;152(4):327-332. doi: 10.23736/S0392-0488.16.05287-X. Epub 2016 Jan 13.G Ital Dermatol Venereol. 2017.PMID: 26761766Clinical Trial.
125.

Role of small intestinal bacterial overgrowth and Helicobacter pylori infection in chronic spontaneous urticaria: a prospective analysis.

Campanati A, Gesuita R, Giannoni M, Piraccini F, Sandroni L, Martina E, Conocchiari L, Bendia E, Di Sario A, Offidani A.Campanati A, et al.Acta Derm Venereol. 2013 Mar 27;93(2):161-4. doi: 10.2340/00015555-1373.Acta Derm Venereol. 2013.PMID: 22858910
126.

Tigecycline accelerates staphylococcal-infected burn wound healing through matrix metalloproteinase-9 modulation.

Simonetti O, Cirioni O, Lucarini G, Orlando F, Ghiselli R, Silvestri C, Brescini L, Rocchi M, Provinciali M, Guerrieri M, Di Primio R, Giacometti A, Offidani A.Simonetti O, et al.J Antimicrob Chemother. 2012 Jan;67(1):191-201. doi: 10.1093/jac/dkr440. Epub 2011 Nov 6.J Antimicrob Chemother. 2012.PMID: 22065244
127.

Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting.

Radi G, Campanati A, Diotallevi F, Molinelli E, Offidani A.Radi G, et al.G Ital Dermatol Venereol. 2019 Apr;154(2):166-169. doi: 10.23736/S0392-0488.18.06095-9. Epub 2018 Sep 18.G Ital Dermatol Venereol. 2019.PMID: 30229640
128.

Insulin resistance, serum insulin and HOMA-R.

Campanati A, Ganzetti G, Di Sario A, Benedetti A, Offidani A.Campanati A, et al.J Gastroenterol. 2013 May;48(5):673. doi: 10.1007/s00535-013-0769-2. Epub 2013 Mar 12.J Gastroenterol. 2013.PMID: 23478937No abstract available.
129.

Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment.

Ganzetti G, Campanati A, Simonetti O, Cataldi I, Giuliodori K, Offidani AM.Ganzetti G, et al.Int J Immunopathol Pharmacol. 2011 Oct-Dec;24(4):1087-91. doi: 10.1177/039463201102400428.Int J Immunopathol Pharmacol. 2011.PMID: 22230416
130.

Coexistence of systemic lupus erythematosus, Hashimoto’s thyroiditis, and bilateral breast cancer in the same patient: a random association?

Molinelli E, Giuliodori K, Campanati A, Brisigotti V, Offidani A.Molinelli E, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(3):55-7. doi: 10.15570/actaapa.2015.13.Acta Dermatovenerol Alp Pannonica Adriat. 2015.PMID: 26399842
131.

Role of Daptomycin on Burn Wound Healing in an Animal Methicillin-Resistant Staphylococcus aureus Infection Model.

Simonetti O, Lucarini G, Orlando F, Pierpaoli E, Ghiselli R, Provinciali M, Castelli P, Guerrieri M, Di Primio R, Offidani A, Giacometti A, Cirioni O.Simonetti O, et al.Antimicrob Agents Chemother. 2017 Aug 24;61(9):e00606-17. doi: 10.1128/AAC.00606-17. Print 2017 Sep.Antimicrob Agents Chemother. 2017.PMID: 28696234Free PMC article.
132.

Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy.

Goteri G, Rupoli S, Campanati A, Zizzi A, Picardi P, Cardelli M, Giantomassi F, Canafoglia L, Marchegiani F, Mozzicafreddo G, Brandozzi G, Stramazzotti D, Ganzetti G, Lisa R, Simonetti O, Offidani A, Federici I, Filosa G, Leoni P.Goteri G, et al.Br J Dermatol. 2012 May;166(5):948-52. doi: 10.1111/j.1365-2133.2012.10818.x.Br J Dermatol. 2012.PMID: 22233400
133.

Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements.

Campanati A, Lagalla G, Penna L, Gesuita R, Offidani A.Campanati A, et al.J Am Acad Dermatol. 2004 Sep;51(3):345-8. doi: 10.1016/j.jaad.2003.09.006.J Am Acad Dermatol. 2004.PMID: 15337974Clinical Trial.
134.

Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis.

Ganzetti G, Campanati A, Santarelli A, Sartini D, Molinelli E, Brisigotti V, Di Ruscio G, Bobyr I, Emanuelli M, Offidani A.Ganzetti G, et al.J Int Med Res. 2016 Sep;44(1 suppl):10-14. doi: 10.1177/0300060515598902.J Int Med Res. 2016.PMID: 27683132Free PMC article.
135.

Urticaria pigmentosa in monozygotic twins.

Offidani A, Cellini A, Simonetti O, Bossi G.Offidani A, et al.Arch Dermatol. 1994 Jul;130(7):935-6.Arch Dermatol. 1994.PMID: 8024286Review.No abstract available.
136.

Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.

Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Giuliano A, Sabato S, Stramazzotti D, Gulini E, Dusi D, De Blasio S, Fabris G, Offidani A.Campanati A, et al.Int J Immunopathol Pharmacol. 2009 Apr-Jun;22(2):371-7. doi: 10.1177/039463200902200214.Int J Immunopathol Pharmacol. 2009.PMID: 19505391Clinical Trial.
137.

Enhanced Efficacy of Combinations of Pexiganan with Colistin Versus Acinetobacter Baumannii in Experimental Sepsis.

Cirioni O, Simonetti O, Pierpaoli E, Barucca A, Ghiselli R, Orlando F, Pelloni M, Minardi D, Trombettoni MM, Guerrieri M, Offidani A, Giacometti A, Provinciali M.Cirioni O, et al.Shock. 2016 Aug;46(2):219-25. doi: 10.1097/SHK.0000000000000584.Shock. 2016.PMID: 26849630
138.

Bullous-vesicular variant of mycosis fungoides presenting as erythema annulare centrifugum: a case report.

Bernardini ML, Brandozzi G, Campanati A, Giangiacomi M, Offidani A.Bernardini ML, et al.J Eur Acad Dermatol Venereol. 2009 Jul;23(7):839-40. doi: 10.1111/j.1468-3083.2008.03030.x. Epub 2009 Jan 19.J Eur Acad Dermatol Venereol. 2009.PMID: 19175475No abstract available.
139.

Efficacy of the Quorum Sensing Inhibitor FS10 Alone and in Combination with Tigecycline in an Animal Model of Staphylococcal Infected Wound.

Simonetti O, Cirioni O, Cacciatore I, Baldassarre L, Orlando F, Pierpaoli E, Lucarini G, Orsetti E, Provinciali M, Fornasari E, Di Stefano A, Giacometti A, Offidani A.Simonetti O, et al.PLoS One. 2016 Jun 2;11(6):e0151956. doi: 10.1371/journal.pone.0151956. eCollection 2016.PLoS One. 2016.PMID: 27253706Free PMC article.
140.

Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.

Simonetti O, Lucarini G, Bernardini ML, Simoncini C, Biagini G, Offidani A.Simonetti O, et al.Br J Dermatol. 2004 May;150(5):940-8. doi: 10.1111/j.1365-2133.2004.05881.x.Br J Dermatol. 2004.PMID: 15149507
141.

Deferred time of delivery of biologic therapies in patients with stabilized psoriasis leads to a ‘perceived satisfaction’: a multicentric study.

Di Altobrando A, Magnano M, Offidani A, Parodi A, Patrizi A, Campanati A, Burlando M, Bardazzi F.Di Altobrando A, et al.J Dermatolog Treat. 2020 Apr 29:1-5. doi: 10.1080/09546634.2020.1759769. Online ahead of print.J Dermatolog Treat. 2020.PMID: 32314934
142.

T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.

Orciani M, Campanati A, Caffarini M, Ganzetti G, Consales V, Lucarini G, Offidani A, Di Primio R.Orciani M, et al.Br J Dermatol. 2017 Jun;176(6):1569-1576. doi: 10.1111/bjd.15078. Epub 2017 Apr 27.Br J Dermatol. 2017.PMID: 27639070
143.

TNF-α inhibitors reduce the pathological Th1 -Th17 /Th2 imbalance in cutaneous mesenchymal stem cells of psoriasis patients.

Campanati A, Orciani M, Lazzarini R, Ganzetti G, Consales V, Sorgentoni G, Di Primio R, Offidani A.Campanati A, et al.Exp Dermatol. 2017 Apr;26(4):319-324. doi: 10.1111/exd.13139. Epub 2016 Oct 24.Exp Dermatol. 2017.PMID: 27376466
144.

Differences in survivin location and Bcl-2 expression in CD30+ lymphoproliferative disorders of the skin compared with systemic anaplastic large cell lymphomas: an immunohistochemical study.

Goteri G, Simonetti O, Rupoli S, Piccinini G, Rubini C, Stramazzotti D, Fazioli F, Capomagi C, Leoni P, Offidani AM, Lo Muzio L.Goteri G, et al.Br J Dermatol. 2007 Jul;157(1):41-8. doi: 10.1111/j.1365-2133.2007.07933.x. Epub 2007 May 2.Br J Dermatol. 2007.PMID: 17484779
145.

Lesional skin chemokine CTACK/CCL27 expression in mycosis fungoides and disease control by IFN-alpha and PUVA therapy.

Goteri G, Rupoli S, Campanati A, Costagliola A, Sabato S, Stramazzotti D, Picardi P, Canafoglia L, Pulini S, Ganzetti G, Offidani AM, Leoni P.Goteri G, et al.Am J Transl Res. 2009 Jan 31;1(2):203-10.Am J Transl Res. 2009.PMID: 19956431Free PMC article.
146.

The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study.

Campanati A, Molinelli E, Ganzetti G, Giuliodori K, Minetti I, Taus M, Catani M, Martina E, Conocchiari L, Offidani A.Campanati A, et al.J Dermatolog Treat. 2017 May;28(3):206-212. doi: 10.1080/09546634.2016.1214666. Epub 2016 Aug 23.J Dermatolog Treat. 2017.PMID: 27552000Clinical Trial.
147.

Skin features in myotonic dystrophy type 1: an observational study.

Campanati A, Giannoni M, Buratti L, Cagnetti C, Giuliodori K, Ganzetti G, Silvestrini M, Provinciali L, Offidani A.Campanati A, et al.Neuromuscul Disord. 2015 May;25(5):409-13. doi: 10.1016/j.nmd.2015.02.013. Epub 2015 Mar 5.Neuromuscul Disord. 2015.PMID: 25813338Clinical Trial.
148.

The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis.

Campanati A, Orciani M, Ganzetti G, Consales V, Di Primio R, Offidani A.Campanati A, et al.J Int Med Res. 2016 Sep;44(1 suppl):6-9. doi: 10.1177/0300060515593229.J Int Med Res. 2016.PMID: 27683131Free PMC article.
149.

Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren.

Gallus S, Naldi L; Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology.Gallus S, et al.Br J Dermatol. 2008 Aug;159(2):433-8. doi: 10.1111/j.1365-2133.2008.08656.x. Epub 2008 Jun 28.Br J Dermatol. 2008.PMID: 18547318Clinical Trial.
150.

Epidemiology of onychomycosis and paronychia in the area of ANCONA (ITALY) over a period of 5 years.

Simonetti O, Bernardini ML, Arzeni D, Cellini A, Barchiesi F, Offidani A.Simonetti O, et al.Mycopathologia. 2004 Oct;158(3):271-4. doi: 10.1007/s11046-004-9615-7.Mycopathologia. 2004.PMID: 15645167
151.

A case of persistent light reaction phenomenon to ketoprofen?

Offidani A, Cellini A, Amerio P, Simonetti O, Bossi G.Offidani A, et al.Eur J Dermatol. 2000 Mar;10(2):153-4.Eur J Dermatol. 2000.PMID: 10694318No abstract available.
152.

Atopic myelitis is not restricted to Japanese patients.

Buratti L, Cagnetti C, Campanati A, Logullo F, Offidani A, Provinciali L.Buratti L, et al.Neurol Sci. 2014 Nov;35(11):1835-7. doi: 10.1007/s10072-014-1832-3. Epub 2014 May 23.Neurol Sci. 2014.PMID: 24852840No abstract available.
153.

Periodontal disease: an oral manifestation of psoriasis or an occasional finding?

Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A.Ganzetti G, et al.Drug Dev Res. 2014 Nov;75 Suppl 1:S46-9. doi: 10.1002/ddr.21194.Drug Dev Res. 2014.PMID: 25381976
154.

Factitious disorders in adults: two cases of unusual skin ulcers.

Giuliodori K, Campanati A, Rosa L, Marconi B, Cellini A, Brandozzi G, Ganzetti G, Simoncini A, Offidani A.Giuliodori K, et al.Acta Dermatovenerol Alp Pannonica Adriat. 2014 Mar;23(1):13-5.Acta Dermatovenerol Alp Pannonica Adriat. 2014.PMID: 24638866
155.

A case of hypertrophic lichen ruber planus of the leg complicated by a squamous cell carcinoma.

Campanati A, Marconi B, Penna L, Giangiacomi M, Offidani A.Campanati A, et al.Int J Dermatol. 2003 May;42(5):415-6. doi: 10.1046/j.1365-4362.2003.01791.x.Int J Dermatol. 2003.PMID: 12755988No abstract available.
156.

In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.

Simonetti O, Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mazzocato S, Kamysz W, Kamysz E, Provinciali M, Giacometti A, Guerrieri M, Offidani A.Simonetti O, et al.Peptides. 2014 May;55:17-22. doi: 10.1016/j.peptides.2014.01.029. Epub 2014 Feb 14.Peptides. 2014.PMID: 24531033
157.

Low dose interferon-alpha2b combined with PUVA is an effective treatment of early stage mycosis fungoides: results of a multicenter study. Cutaneous-T Cell Lymphoma Multicenter Study Group.

Rupoli S, Barulli S, Guiducci B, Offidani M, Mozzicafreddo G, Simonacci M, Filosa G, Giacchetti A, Ricotti G, Brandozzi G, Cataldi I, Serresi S, Ceschini R, Bugatti L, Offidani A, Giangiacomi M, Brancorsini D, Leoni P.Rupoli S, et al.Haematologica. 1999 Sep;84(9):809-13.Haematologica. 1999.PMID: 10477454Clinical Trial.
158.

Tinea capitis due to Microsporum gypseum in an adult.

Offidani A, Simoncini C, Arzeni D, Cellini A, Amerio P, Scalise G.Offidani A, et al.Mycoses. 1998 May-Jun;41(5-6):239-41. doi: 10.1111/j.1439-0507.1998.tb00331.x.Mycoses. 1998.PMID: 9715640Review.
159.

In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.

Simonetti O, Arzeni D, Ganzetti G, Silvestri C, Cirioni O, Gabrielli E, Castelletti S, Kamysz W, Kamysz E, Scalise G, Offidani A, Barchiesi F.Simonetti O, et al.Br J Dermatol. 2009 Aug;161(2):249-52. doi: 10.1111/j.1365-2133.2009.09166.x. Epub 2009 Apr 29.Br J Dermatol. 2009.PMID: 19438437
160.

Clinical and prognostic significance of survivin, AKT and VEGF in primary mucosal oral melanoma.

Simonetti O, Lucarini G, Rubini C, Lazzarini R, DI Primio R, Offidani A.Simonetti O, et al.Anticancer Res. 2015 Apr;35(4):2113-20.Anticancer Res. 2015.PMID: 25862867
161.

Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis.

Fumelli C, Marconi A, Salvioli S, Straface E, Malorni W, Offidani AM, Pellicciari R, Schettini G, Giannetti A, Monti D, Franceschi C, Pincelli C.Fumelli C, et al.J Invest Dermatol. 2000 Nov;115(5):835-41. doi: 10.1046/j.1523-1747.2000.00140.x.J Invest Dermatol. 2000.PMID: 11069621
162.

The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients.

Ganzetti G, Campanati A, Scocco V, Brugia M, Tocchini M, Liberati G, Giuliodori K, Brisigotti V, Offidani A.Ganzetti G, et al.Acta Derm Venereol. 2014 Nov;94(6):715-7. doi: 10.2340/00015555-1801.Acta Derm Venereol. 2014.PMID: 24789007No abstract available.
163.

New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.

Simonetti O, Lucarini G, Morroni G, Orlando F, Lazzarini R, Zizzi A, Brescini L, Provinciali M, Giacometti A, Offidani A, Cirioni O.Simonetti O, et al.Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02062-19. doi: 10.1128/AAC.02062-19. Print 2020 Mar 24.Antimicrob Agents Chemother. 2020.PMID: 31932371
164.

Efficacy of oral zinc and nicotinamide as maintenance therapy for mild-moderate hidradenitis suppurativa: a controlled retrospective clinical study.

Molinelli E, Brisigotti V, Campanati A, Sapigni C, Giacchetti A, Cota C, Offidani A.Molinelli E, et al.J Am Acad Dermatol. 2020 Apr 24:S0190-9622(20)30708-8. doi: 10.1016/j.jaad.2020.04.092. Online ahead of print.J Am Acad Dermatol. 2020.PMID: 32339699No abstract available.
165.

In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection.

Silvestri C, Cirioni O, Arzeni D, Ghiselli R, Simonetti O, Orlando F, Ganzetti G, Staffolani S, Brescini L, Provinciali M, Offidani A, Guerrieri M, Giacometti A.Silvestri C, et al.Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1759-64. doi: 10.1007/s10096-011-1498-1. Epub 2011 Dec 11.Eur J Clin Microbiol Infect Dis. 2012.PMID: 22160846
166.

Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections.

Ghiselli R, Cirioni O, Giacometti A, Scalise A, Simonetti O, Mocchegiani F, Orlando F, Goteri G, Della Vittoria A, Filosa A, Silvestri C, Offidani A, Bertani A, Scalise G, Saba V.Ghiselli R, et al.J Surg Res. 2008 Jan;144(1):74-81. doi: 10.1016/j.jss.2007.02.051. Epub 2007 Jun 14.J Surg Res. 2008.PMID: 17574587
167.

The mesenchymal stem cell profile in psoriasis.

Orciani M, Campanati A, Salvolini E, Lucarini G, Di Benedetto G, Offidani A, Di Primio R.Orciani M, et al.Br J Dermatol. 2011 Sep;165(3):585-92. doi: 10.1111/j.1365-2133.2011.10438.x. Epub 2011 Aug 9.Br J Dermatol. 2011.PMID: 21623755
168.

Microvessel density and VEGF, HIF-1α expression in primary oral melanoma: correlation with prognosis.

Simonetti O, Lucarini G, Rubini C, Goteri G, Zizzi A, Staibano S, Campanati A, Ganzetti G, Di Primio R, Offidani A.Simonetti O, et al.Oral Dis. 2013 Sep;19(6):620-7. doi: 10.1111/odi.12048. Epub 2012 Dec 27.Oral Dis. 2013.PMID: 23279259
169.

Reciprocal altered expression of E-cadherin and P-cadherin in mucous membrane pemphigoid.

Santarelli A, Di Fede O, Carinci F, Rubini C, Ganzetti G, Perrone D, Simonetti O, Offidani A, Re M, Perrone D, Pannone G, Lo Muzio L.Santarelli A, et al.Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2 Suppl):103-6. doi: 10.1177/03946320110240S218.Int J Immunopathol Pharmacol. 2011.PMID: 21781454
170.

In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.

Simonetti O, Silvestri C, Arzeni D, Cirioni O, Kamysz W, Conte I, Staffolani S, Orsetti E, Morciano A, Castelli P, Scalise A, Kamysz E, Offidani AM, Giacometti A, Barchiesi F.Simonetti O, et al.Mycoses. 2014 Apr;57(4):233-9. doi: 10.1111/myc.12148. Epub 2013 Oct 16.Mycoses. 2014.PMID: 26058322
171.

Clinical, power Doppler sonography and histological assessment of the psoriatic plaque: short-term monitoring in patients treated with etanercept.

Gutierrez M, De Angelis R, Bernardini ML, Filippucci E, Goteri G, Brandozzi G, Lemme G, Campanati A, Grassi W, Offidani A.Gutierrez M, et al.Br J Dermatol. 2011 Jan;164(1):33-7. doi: 10.1111/j.1365-2133.2010.10026.x. Epub 2010 Nov 11.Br J Dermatol. 2011.PMID: 21070199
172.

Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds.

Simonetti O, Cirioni O, Ghiselli R, Goteri G, Orlando F, Monfregola L, De Luca S, Zizzi A, Silvestri C, Veglia G, Giacometti A, Guerrieri M, Offidani A, Scaloni A.Simonetti O, et al.Eur J Clin Microbiol Infect Dis. 2012 Nov;31(11):3047-55. doi: 10.1007/s10096-012-1663-1. Epub 2012 Jun 23.Eur J Clin Microbiol Infect Dis. 2012.PMID: 22729599
173.

Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis.

Campanati A, Orciani M, Consales V, Lazzarini R, Ganzetti G, Di Benedetto G, Di Primio R, Offidani A.Campanati A, et al.Arch Dermatol Res. 2014 Dec;306(10):915-20. doi: 10.1007/s00403-014-1493-3. Epub 2014 Aug 27.Arch Dermatol Res. 2014.PMID: 25160906
174.

In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.

Barchiesi F, Silvestri C, Arzeni D, Ganzetti G, Castelletti S, Simonetti O, Cirioni O, Kamysz W, Kamysz E, Spreghini E, Abruzzetti A, Riva A, Offidani AM, Giacometti A, Scalise G.Barchiesi F, et al.Med Mycol. 2009 May;47(3):321-6. doi: 10.1080/13693780802641920. Epub 2008 Dec 27.Med Mycol. 2009.PMID: 19115137
175.

Prevalence of atopic dermatitis in Italian schoolchildren: factors affecting its variation.

Naldi L, Parazzini F, Gallus S; GISED Study Centres.Naldi L, et al.Acta Derm Venereol. 2009;89(2):122-5. doi: 10.2340/00015555-0591.Acta Derm Venereol. 2009.PMID: 19325993
176.

Zoon’s balanitis treated with imiquimod 5% cream.

Marconi B, Campanati A, Simonetti O, Savelli A, Conocchiari L, Santinelli A, Pisa E, Offidani A.Marconi B, et al.Eur J Dermatol. 2010 Jan-Feb;20(1):134-5. doi: 10.1684/ejd.2010.0829. Epub 2009 Nov 4.Eur J Dermatol. 2010.PMID: 19889590No abstract available.
177.

Lichen striatus in adults and pimecrolimus: open, off-label clinical study.

Campanati A, Brandozzi G, Giangiacomi M, Simonetti O, Marconi B, Offidani AM.Campanati A, et al.Int J Dermatol. 2008 Jul;47(7):732-6. doi: 10.1111/j.1365-4632.2008.03654.x.Int J Dermatol. 2008.PMID: 18613885Clinical Trial.
178.

VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases.

Simonetti O, Lucarini G, Campanati A, Goteri G, Zizzi A, Marconi B, Ganzetti G, Minardi D, Di Primio R, Offidani A.Simonetti O, et al.J Dermatol Sci. 2009 Jun;54(3):205-8. doi: 10.1016/j.jdermsci.2008.12.012. Epub 2009 Feb 1.J Dermatol Sci. 2009.PMID: 19188045No abstract available.
179.

Pronounced and early acne in Apert’s syndrome: a case successfully treated with oral isotretinoin.

Campanati A, Marconi B, Penna L, Paolinelli M, Offidani A.Campanati A, et al.Eur J Dermatol. 2002 Sep-Oct;12(5):496-8.Eur J Dermatol. 2002.PMID: 12370145
180.

Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis.

Campanati A, Orciani M, Gorbi S, Regoli F, Di Primio R, Offidani A.Campanati A, et al.Br J Dermatol. 2012 Jul;167(1):68-76. doi: 10.1111/j.1365-2133.2012.10900.x. Epub 2012 Jun 6.Br J Dermatol. 2012.PMID: 22356229
181.

The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection.

Simonetti O, Cirioni O, Mocchegiani F, Cacciatore I, Silvestri C, Baldassarre L, Orlando F, Castelli P, Provinciali M, Vivarelli M, Fornasari E, Giacometti A, Offidani A.Simonetti O, et al.Int J Mol Sci. 2013 Aug 7;14(8):16321-32. doi: 10.3390/ijms140816321.Int J Mol Sci. 2013.PMID: 23965956Free PMC article.
182.

Effect of etanercept on insulin sensitivity in nine patients with psoriasis.

Marra M, Campanati A, Testa R, Sirolla C, Bonfigli AR, Franceschi C, Marchegiani F, Offidani A.Marra M, et al.Int J Immunopathol Pharmacol. 2007 Oct-Dec;20(4):731-6. doi: 10.1177/039463200702000408.Int J Immunopathol Pharmacol. 2007.PMID: 18179745
183.

The successful off-label use of photodynamic therapy for classic porokeratosis of Mibelli: case report.

Giuliodori K, Campanati A, Ganzetti G, Conocchiari L, Cataldi I, Simonetti O, Giangiacomi M, Offidani A.Giuliodori K, et al.Dermatol Ther. 2011 Sep-Oct;24(5):501-4. doi: 10.1111/j.1529-8019.2012.01473.x.Dermatol Ther. 2011.PMID: 22353157
184.

RNAIII-inhibiting peptide enhances healing of wounds infected with methicillin-resistant Staphylococcus aureus.

Simonetti O, Cirioni O, Ghiselli R, Goteri G, Scalise A, Orlando F, Silvestri C, Riva A, Saba V, Madanahally KD, Offidani A, Balaban N, Scalise G, Giacometti A.Simonetti O, et al.Antimicrob Agents Chemother. 2008 Jun;52(6):2205-11. doi: 10.1128/AAC.01340-07. Epub 2008 Apr 7.Antimicrob Agents Chemother. 2008.PMID: 18391046Free PMC article.
185.

Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine.

Bernardini ML, D’Angelo G, Oggiano N, Campanati A, Ficcadenti A, Coppa GV, Offidani A.Bernardini ML, et al.Acta Derm Venereol. 2006;86(4):359-60. doi: 10.2340/00015555-0071.Acta Derm Venereol. 2006.PMID: 16874427No abstract available.
186.

The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis.

Campanati A, Ganzetti G, Di Sario A, Damiani A, Sandroni L, Rosa L, Benedetti A, Offidani A.Campanati A, et al.J Gastroenterol. 2013 Jul;48(7):839-46. doi: 10.1007/s00535-012-0678-9. Epub 2012 Oct 13.J Gastroenterol. 2013.PMID: 23065020
187.

Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression.

Simonetti O, Lucarini G, Cirioni O, Zizzi A, Orlando F, Provinciali M, Di Primio R, Giacometti A, Offidani A.Simonetti O, et al.Burns. 2013 Jun;39(4):776-87. doi: 10.1016/j.burns.2012.09.013. Epub 2012 Oct 22.Burns. 2013.PMID: 23084631
188.

Plasma membrane fluidity of keratinocytes of normal and psoriatic skin: a study using fluorescence anisotropy of trimethylammoniumdiphenylhexatriene (TMA-DPH).

Simonetti O, Ferretti G, Offidani AM, Gervasi P, Curatola G, Bossi G.Simonetti O, et al.Arch Dermatol Res. 1996;288(1):51-4. doi: 10.1007/BF02505043.Arch Dermatol Res. 1996.PMID: 8750935
189.

Skin metastases from prostate cancer associated with malignant melanoma.

Offidani A, Simonetti O, Cellini A, Giangiacomi M, Brandozzi G, Minardi D, Muzzonigro G.Offidani A, et al.Cutis. 1997 May;59(5):278-80.Cutis. 1997.PMID: 9169271
190.

In vitro activity of the lipopeptide PAL-Lys-Lys-NH2, alone and in combination with antifungal agents, against clinical isolates of Candida spp.

Kamysz E, Simonetti O, Cirioni O, Arzeni D, Ganzetti G, Campanati A, Giacometti A, Gabrielli E, Silvestri C, Kamysz W, Offidani A, Barchiesi F.Kamysz E, et al.Peptides. 2011 Jan;32(1):99-103. doi: 10.1016/j.peptides.2010.10.022. Epub 2010 Nov 3.Peptides. 2011.PMID: 21055432
191.

Plasma oxidation status and antioxidant capacity in psoriatic children.

Bacchetti T, Simonetti O, Ricotti F, Offidani A, Ferretti G.Bacchetti T, et al.Arch Dermatol Res. 2020 Jan;312(1):33-39. doi: 10.1007/s00403-019-01976-z. Epub 2019 Sep 17.Arch Dermatol Res. 2020.PMID: 31531730
192.

Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.

Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.Simonetti O, et al.Cancer. 2002 Nov 1;95(9):1963-70. doi: 10.1002/cncr.10888.Cancer. 2002.PMID: 12404291
193.

Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.

Simonetti O, Goteri G, Lucarini G, Filosa A, Pieramici T, Rubini C, Biagini G, Offidani A.Simonetti O, et al.Eur J Cancer. 2006 May;42(8):1181-7. doi: 10.1016/j.ejca.2006.01.043. Epub 2006 Apr 27.Eur J Cancer. 2006.PMID: 16644201
194.

Abnormalities of plasma lipoprotein composition and fluidity in psoriasis.

Ferretti G, Alleva R, Taus M, Simonetti O, Cinti B, Offidani AM, Bossi G, Curatola G.Ferretti G, et al.Acta Derm Venereol. 1994 May;74(3):171-5. doi: 10.2340/0001555574171175.Acta Derm Venereol. 1994.PMID: 7915455
195.

CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.

Campanati A, Goteri G, Simonetti O, Ganzetti G, Giuliodori K, Stramazzotti D, Morichetti D, Bernardini ML, Mannello B, Fabris G, Offidani A.Campanati A, et al.Br J Dermatol. 2007 Dec;157(6):1155-60. doi: 10.1111/j.1365-2133.2007.08200.x. Epub 2007 Oct 4.Br J Dermatol. 2007.PMID: 17916208Clinical Trial.
196.

Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry.

Gisondi P, Cazzaniga S, Chimenti S, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group.Gisondi P, et al.Br J Dermatol. 2015 Jun;172(6):1613-1620. doi: 10.1111/bjd.13539. Epub 2015 Mar 17.Br J Dermatol. 2015.PMID: 25401733
197.

Normolipemic plane xanthomatosis with acute development preceding the clinical onset of rheumatoid arthritis.

Campanati A, Goteri G, Simonetti O, Marconi B, Brandozzi G, Ganzetti G, Giuliodori K, Offidani A.Campanati A, et al.J Cutan Pathol. 2009 Oct;36 Suppl 1:13-5. doi: 10.1111/j.1600-0560.2009.01191.x. Epub 2009 Jun 5.J Cutan Pathol. 2009.PMID: 19508500No abstract available.
198.

In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness:an immunohistochemical study.

Simonetti O, Goteri G, Lucarini G, Rubini C, Stramazzotti D, Lo Muzio L, Biagini G, Offidani A.Simonetti O, et al.Int J Immunopathol Pharmacol. 2007 Apr-Jun;20(2):325-33. doi: 10.1177/039463200702000212.Int J Immunopathol Pharmacol. 2007.PMID: 17624244
199.

Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.

Arzeni D, Del Poeta M, Simonetti O, Offidani AM, Lamura L, Balducci M, Cester N, Giacometti A, Scalise G.Arzeni D, et al.Eur J Epidemiol. 1997 Jun;13(4):447-50. doi: 10.1023/a:1007366722235.Eur J Epidemiol. 1997.PMID: 9258552
200.

Papillary hidradenoma: immunohistochemical analysis of steroid receptor profile with a focus on apocrine differentiation.

Offidani A, Campanati A.Offidani A, et al.J Clin Pathol. 1999 Nov;52(11):829-32. doi: 10.1136/jcp.52.11.829.J Clin Pathol. 1999.PMID: 10690173Free PMC article.
201.

[Clinical evaluation of a preparation for topical use with a urea and allantoin base].

Offidani AM, Cataldi I, Rossi R, Bossi G, La Macchia G.G Ital Dermatol Venereol. 1985 Jan-Feb;120(1):I-IV.PMID: 4007929Italian.No abstract available.
202.

Role of cytomegalovirus replication in alopecia areata pathogenesis.

Offidani A, Amerio P, Bernardini ML, Feliciani C, Bossi G.J Cutan Med Surg. 2000 Apr;4(2):63-5. doi: 10.1177/120347540000400204.PMID: 11179926
203.

[Gilbert’s pityriasis rosea involving the feet].

Offidani A, Cellini A.Ann Dermatol Venereol. 1998 Sep;125(9):608.PMID: 9805553French.No abstract available.
204.

Differential expression of nicotinamide N-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study.

Sartini D, Pompei V, Lucarini G, Rubini C, Molinelli E, Brisigotti V, Salvolini E, Campanati A, Offidani A, Emanuelli M.J Eur Acad Dermatol Venereol. 2020 Mar;34(3):e121-e123. doi: 10.1111/jdv.16048. Epub 2019 Nov 28.PMID: 31705831No abstract available.
205.

General practitioners’ accuracy in diagnosing skin cancers.

Offidani A, Simonetti O, Bernardini ML, Alpagut A, Cellini A, Bossi G.Dermatology. 2002;205(2):127-30. doi: 10.1159/000063887.PMID: 12218226
206.

HLA-B27 negative ankylosing spondylitis and hidradenitis suppurativa: report of a case.

Grassi W, Offidani AM, Blasetti P, Simonetti O, Cervini C.Clin Rheumatol. 1988 Jun;7(2):278-83. doi: 10.1007/BF02204469.PMID: 3262031
207.

Mesenchymal stem cell profile in actinic keratosis and its modification after topical application of ingenol mebutate.

Campanati A, Bobyr I, Sorgentoni G, Diotallevi F, Caffarini M, Pellegrino P, Di Primio R, Offidani A, Orciani M.J Eur Acad Dermatol Venereol. 2020 Mar;34(3):e148-e149. doi: 10.1111/jdv.16058.PMID: 31709665No abstract available.
208.

In vitro activity of posaconazole against clinical isolates of dermatophytes.

Barchiesi F, Arzeni D, Camiletti V, Simonetti O, Cellini A, Offidani AM, Scalise G.J Clin Microbiol. 2001 Nov;39(11):4208-9. doi: 10.1128/JCM.39.11.4208-4209.2001.PMID: 11682563Free PMC article.
209.

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry.

Piaserico S, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Peserico A, Naldi L; Psocare Study Group.J Am Acad Dermatol. 2014 Feb;70(2):257-62.e3. doi: 10.1016/j.jaad.2013.10.019. Epub 2013 Dec 16.PMID: 24355410
210.

Adult rhabdomyoma: report of two cases of rhabdomyoma of the lip and of the eyelid.

Verdolini R, Goteri G, Brancorsini D, Collina G, Simonetti O, Offidani A, Giangiacomi M.Am J Dermatopathol. 2000 Jun;22(3):264-7. doi: 10.1097/00000372-200006000-00011.PMID: 10871072
211.

Treatment of scabies with ivermectin.

Offidani A, Cellini A, Simonetti O, Fumelli C.Eur J Dermatol. 1999 Mar;9(2):100-1.PMID: 10066955
212.

Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry.

Gisondi P, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group.J Eur Acad Dermatol Venereol. 2013 Jan;27(1):e30-41. doi: 10.1111/j.1468-3083.2012.04450.x. Epub 2012 Feb 7.PMID: 22313340
213.

Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association.

Goteri G, Ranaldi R, Simonetti O, Capretti R, Menzo S, Stramazzotti D, Morichetti D, Offidani AM, Rupoli S, Leoni P.Leuk Lymphoma. 2007 Nov;48(11):2184-8. doi: 10.1080/10428190701618250.PMID: 17926178
214.

Description of a patient with difficult nosological classification: Goldenhar syndrome or Townes-Brocks syndrome?

Gabrielli O, Bonifazi V, Offidani AM, Cellini A, Coppa GV, Giorgi PL.Minerva Pediatr. 1993 Nov;45(11):459-62.PMID: 8133838
215.

In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes.

Simonetti O, Ganzetti G, Arzeni D, Campanati A, Marconi B, Silvestri C, Cirioni O, Gabrielli E, Lenci I, Kamysz W, Kamysz E, Giacometti A, Scalise G, Barchiesi F, Offidani A.Peptides. 2009 Oct;30(10):1794-7. doi: 10.1016/j.peptides.2009.06.033. Epub 2009 Jul 8.PMID: 19591887
216.

A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.

Campanati A, Berardi R, Onofri A, Pierantoni C, Conte I, Giuliodori K, Molinelli E, Marcucci F, Cascinu S, Offidani A.Ann Oncol. 2012 Apr;23(4):1081-2. doi: 10.1093/annonc/mds026.PMID: 22457259No abstract available.
217.

Safety update of etanercept treatment for moderate to severe plaque psoriasis.

Campanati A, Diotallevi F, Martina E, Paolinelli M, Radi G, Offidani A.Expert Opin Drug Saf. 2020 Apr;19(4):439-448. doi: 10.1080/14740338.2020.1740204. Epub 2020 Mar 19.PMID: 32178543
218.

Electrophoretic karyotyping and antifungal susceptibility patterns of Candida parapsilosis clinical isolates causing deep and superficial fungal infections.

Barchiesi F, Di Francesco LF, Arzeni D, Caselli F, Simonetti O, Cellini A, Giacometti A, Offidani AM, Scalise G.Mycopathologia. 2001;149(3):117-21. doi: 10.1023/a:1007279213485.PMID: 11307593
219.

Psychopathology, personality, and marital relationship in patients undergoing in vitro fertilization procedures.

Salvatore P, Gariboldi S, Offidani A, Coppola F, Amore M, Maggini C.Fertil Steril. 2001 Jun;75(6):1119-25. doi: 10.1016/s0015-0282(01)01775-7.PMID: 11384636
220.

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study.

Molinelli E, Campanati A, Brisigotti V, Sapigni C, Paolinelli M, Offidani A.Dermatol Ther (Heidelb). 2020 Apr 27. doi: 10.1007/s13555-020-00379-7. Online ahead of print.PMID: 32342443
221.

Familial supernumerary nipples and breasts.

Cellini A, Offidani A.Dermatology. 1992;185(1):56-8. doi: 10.1159/000247404.PMID: 1638072
222.

Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical study.

Tucci MG, Offidani A, Lucarini G, Simonelli L, Amati S, Cellini A, Biagini G, Ricotti G.J Eur Acad Dermatol Venereol. 1998 Mar;10(2):118-24.PMID: 9553907
223.

Expression of eotaxin, interleukin 13 and tumour necrosis factor-alpha in dermatitis herpetiformis.

Amerio P, Verdolini R, Giangiacomi M, Proietto G, Feliciani C, Offidani A, Bossi G.Br J Dermatol. 2000 Nov;143(5):974-8. doi: 10.1046/j.1365-2133.2000.03765.x.PMID: 11069505
224.

Subclinical joint involvement in psoriasis: magnetic resonance imaging and X-ray findings.

Offidani A, Cellini A, Valeri G, Giovagnoni A.Acta Derm Venereol. 1998 Nov;78(6):463-5. doi: 10.1080/000155598442809.PMID: 9833050
225.

Hypomelanosis of Ito: a case report with clinical and ultrastructural data.

Cellini A, Morroni M, Simonetti O, Offidani A.J Eur Acad Dermatol Venereol. 1998 Jan;10(1):73-6.PMID: 9552763
226.

[Quinquad’s folliculitis decalvans and tufted hair].

Offidani A, Cellini A, Giangiacomi M, Bossi G.Ann Dermatol Venereol. 1994;121(4):319-21.PMID: 7702251French.
227.

An epidemiological study on cutaneous diseases of agricultural workers authorized to use pesticides.

Cellini A, Offidani A.Dermatology. 1994;189(2):129-32. doi: 10.1159/000246815.PMID: 8075438
228.

Guess what! Acute haemorrhagic oedema of the skin in infancy.

Offidani A, Cellini A, Bossi G.Eur J Dermatol. 2001 Jan-Feb;11(1):63-4.PMID: 11174143No abstract available.
229.

Decreased membrane fluidity in polymorphonuclear cells in psoriasis.

Offidani AM, Simonetti O, Cerioni S, Ferretti G, Marchiseppe I, Postiglione MR, Valentino M.Boll Soc Ital Biol Sper. 1988 Jun;64(6):495-500.PMID: 3190902No abstract available.
230.

Changes of plasma lipids and erythrocyte membrane fluidity in psoriatic children.

Ferretti G, Simonetti O, Offidani AM, Messini L, Cinti B, Marshiseppe I, Bossi G, Curatola G.Pediatr Res. 1993 May;33(5):506-9. doi: 10.1203/00006450-199305000-00017.PMID: 8511025
231.

Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern?

Ganzetti G, Giuliodori K, Campanati A, Offidani A.Skinmed. 2014 Mar-Apr;12(2):128-30.PMID: 24933858No abstract available.
232.

Membrane fluidity changes in polymorphonuclear leukocytes and erythrocytes in psoriasis.

Offidani AM, Simonetti O, Ferretti G, Curatola G, Bossi G.Acta Derm Venereol Suppl (Stockh). 1989;146:39-41.PMID: 2609879
233.

Changes in membrane properties of erythrocytes and polymorphonuclear cells in psoriasis.

Ferretti G, Offidani AM, Simonetti O, Valentino M, Curatola G, Bossi G.Biochem Med Metab Biol. 1989 Apr;41(2):132-8. doi: 10.1016/0885-4505(89)90018-2.PMID: 2719858
234.

A case of follicular mycosis fungoides with follicular mucinosis: a rare association.

Campanati A, Giangiacomi M, Goteri G, Penna L, Turtù S, Offidani AM.Am J Dermatopathol. 2002 Oct;24(5):423-6. doi: 10.1097/00000372-200210000-00009.PMID: 12357205
235.

Purely cutaneous Langerhans’ cell histiocytosis in an adult woman.

Campanati A, Simonetti O, Marconi B, Giuliodori K, Ganzetti G, Brandozzi G, Bernardini ML, Ranaldi R, Offidani A.Acta Derm Venereol. 2009;89(3):299-301. doi: 10.2340/00015555-0614.PMID: 19479131No abstract available.
236.

Hypereosinophilic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome?

Offidani A, Bernardini ML, Simonetti O, Simoncini C, Giangiacomi M, Bossi G.Br J Dermatol. 2000 Sep;143(3):675-7. doi: 10.1111/j.1365-2133.2000.03750.x.PMID: 10971369No abstract available.
237.

[Sjögren-Larsson Syndrome].

Offidani AM, Ambrosii D, Cataldi I.G Ital Dermatol Venereol. 1983 Sep-Oct;118(5):315-8.PMID: 6667967Italian.No abstract available.
238.

Chordoma with multiple skin metastases.

Peramezza C, Cellini A, Berardi P, Benvenuti S, Offidani A.Dermatology. 1993;186(4):266-8. doi: 10.1159/000247368.PMID: 8513193
239.

Novel Therapeutic Approaches and Targets for Treatment of Neutrophilic Dermatoses.

Molinelli E, Brisigotti V, Paolinelli M, Offidani A.Curr Pharm Biotechnol. 2020 May 2. doi: 10.2174/1389201021666200503050803. Online ahead of print.PMID: 32359335
240.

[Wasp stings with localized eruption].

Offidani A, Andreina C, Mattioli D, Cellini A.Ann Dermatol Venereol. 2000 Aug-Sep;127(8-9):747.PMID: 11011170French.No abstract available.
241.

Hemangioma in POEMS syndrome: an atypical clinical and histological presentation.

Ganzetti G, Campanati A, Goteri G, Simonetti O, Offidani A.J Eur Acad Dermatol Venereol. 2012 Jul;26(7):927-8. doi: 10.1111/j.1468-3083.2011.04174.x. Epub 2011 Jul 13.PMID: 21749469No abstract available.
242.

Bilateral squamous cell carcinoma of the feet associated with human papillomavirus type 16 infection.

Campanati A, Dusi D, Conocchiari L, Brancorsini D, Mandolesi A, Grassetti L, Di Bendetto G, Offidani A.Int J Dermatol. 2013 Dec;52(12):1608-9. doi: 10.1111/j.1365-4632.2012.05466.x. Epub 2013 Jun 7.PMID: 23742630No abstract available.
243.

Lipoprotein peroxidation in adult psoriatic patients.

Offidani AM, Ferretti G, Taus M, Simonetti O, Dousset N, Valdiguie P, Curatola G, Bossi G.Acta Derm Venereol Suppl (Stockh). 1994;186:38-40.PMID: 8073834
244.

Cutaneous carcinomas and preinvasive neoplastic lesions. Role of MMP-2 and MMP-9 metalloproteinases in neoplastic invasion and their relationship with proliferative activity and p53 expression.

Verdolini R, Amerio P, Goteri G, Bugatti L, Lucarini G, Mannello B, Filosa G, Offidani A, Brancorsini D, Biagini G, Giangiacomi M.J Cutan Pathol. 2001 Mar;28(3):120-6. doi: 10.1034/j.1600-0560.2001.028003120.x.PMID: 11168762
245.

Pityriasis rosea associated with herpesvirus 7 DNA.

Offidani A, Pritelli E, Simonetti O, Cellini A, Giornetta L, Bossi G.J Eur Acad Dermatol Venereol. 2000 Jul;14(4):313-4. doi: 10.1046/j.1468-3083.2000.00050.x.PMID: 11204526No abstract available.
246.

[Lewandoswsky and Lutz epidermodysplasia verruciformis].

Offidani AM, Paolorosso A, Capodaglio L.G Ital Dermatol Venereol. 1984 Sep-Oct;119(5):333-6.PMID: 6510954Italian.No abstract available.
247.

Plasma lipid changes in psoriatic children.

Simonetti O, Ferretti G, Salvi A, Offidani AM, Bossi G.Dermatology. 1992;185(2):96-100. doi: 10.1159/000247421.PMID: 1421638
248.

[Histological and ultrastructural aspects of Laugier’s disease. Presentation of a case].

Offidani A, Morroni M, Lazzaretti G, Mambelli V.G Ital Dermatol Venereol. 1987 Oct;122(10):535-8.PMID: 3443467Italian.No abstract available.
249.

[HLA-DR antigens and alopecia areata].

Offidani AM, Simonetti O, Politi A, Salvi A, Gabrielli A, Bossi G.G Ital Dermatol Venereol. 1988 Sep;123(9):409-12.PMID: 3243579Italian.No abstract available.
250.

In vitro activity of terbinafine against clinical isolates of dermatophytes.

Arzeni D, Barchiesi F, Compagnucci P, Cellini A, Simonetti O, Offidani AM, Scalise G.Med Mycol. 1998 Aug;36(4):235-7.PMID: 9776840
251.

The “metabolic burst” in polymorphonuclear leukocytes: in vitro reduction by scale extract of psoriasis.

Muti S, Offidani AM, Fortunati R, Silveri F, Piergiacomi G.Boll Soc Ital Biol Sper. 1988 Feb;64(2):123-30.PMID: 3166789No abstract available.
252.

[Increase in chemiluminescence induced by receptor-independent stimulation of polymorphonuclear cells from psoriatic patients].

Battoccoli E, Tappa MM, Simonetti O, Marchiseppe I, Valentino M, Offidani AM.Boll Soc Ital Biol Sper. 1989 Dec;65(12):1133-9.PMID: 2627328Italian.
253.

[Hand, foot and mouth disease. Study of 25 cases].

Offidani A, Ricotti G, Bossi G.G Ital Dermatol Venereol. 1986 Nov-Dec;121(6):399-403.PMID: 3030930Italian.No abstract available.
254.

Well-differentiated squamous cell carcinoma of the penis associated with HPV type 33.

Amerio P, Offidani A, Cellini A, Bossi G.Int J Dermatol. 1998 Feb;37(2):128-30. doi: 10.1046/j.1365-4362.1998.00413.x.PMID: 9542670No abstract available.
255.

[Chemotaxis of polymorphonucleated leukocytes in the presence of skin extracts and psoriatic scales].

Offidani A, Valentino M, Fortunati R, Fidecicchi G, Bossi G.G Ital Dermatol Venereol. 1988 Mar;123(3):71-4.PMID: 3410501Italian.No abstract available.
Clinica Dermatologica Ancona
via Conca 71 - 60126 Ancona (AN)
info@clinicadermatologicancona.it
+39 071 596 3432
www.clinicadermatologicancona.it
Università Politecnica delle Marche
© 2020 Clinica Dermatologica Ancona

[Credits] Web: Perugini Multimedia – Social Media: Campagne Virali